针对自身免疫性疾病的补充向治疗
Cong-Qiu Chu1,2
1Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, Portland, OR, USA.
Medical review (2021)
|January 29, 2024
概括
针对性疗法正在通过抑制补充活性来治疗自身免疫性疾病. 小干扰RNA (siRNA) 是有前途的,可能与自身抗体减少相结合,可有效治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 治疗方法 治疗方法
背景情况:
- 补充介导血解治疗显示出成功,推动了向治疗的发展.
- 疗法正在从罕见的自身免疫性疾病扩展到更常见的疾病.
- 各种药物类别 (小分子,,单克隆抗体,siRNA) 准补充活性.
研究的目的:
- 探索针对自身免疫性疾病的向治疗方法的开发.
- 评估小干扰RNA (siRNA) 作为治疗工具的潜力.
- 研究复杂的自身免疫性疾病的组合策略.
主要方法:
- 审查目前用于补充向治疗的药物开发.
- 对抑制补充产生的小干扰RNA (siRNA) 机制的分析.
- 探索双模式治疗方法.
主要成果:
- 针对补充介导疾病的向疗法是成功和安全的.
- siRNA正在成为抑制补充的强有力的治疗剂.
- 组合疗法 (siRNA加自抗体降低) 在临床上是可行的.
结论:
- 针对性疗法正在扩大自身免疫性疾病,利用补充抑制.
- siRNA提供了一种有前途的方法来抑制补充剂的产生.
- 结合的siRNA和自身抗体降低策略可能会显著影响自身免疫性疾病的管理.
更多相关视频
11:31High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
Published on: August 16, 2019
7.9K
06:29Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
30.6K
相关概念视频
01:29Autoimmune Disorders
439
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
439
01:27Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
01:40Cell-mediated Immune Responses
68.3K
Overview
68.3K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
166
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
166